EXO1 and cancer: Exo1 meets all criteria in such an important DNA replication-coupled excision repair pathway as its deficiency diversifies the neoantigen and benefits the immunotherapy cancer patients (Cortez, 2019; Vali-Pour et al., 2022; Wang et al., 2022).